Macrophage-derived netrin-1 drives adrenergic nerve–associated lung fibrosis is a research paper published in Journal of Clinical Investigation (2021). On theSindex it has a DataRank of 0. It has been cited 114 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Parker B. Francis Foundation
Grant: N/A
ATS Foundation
Grant: AWD0002487
U.S. Department of Defense
Grant: DOD PR192454 (H.S.);,DOD W81XWH1810629 (D.M.G.);,DOD PR170078 (E.L.H.)
National Institutes of Health
Grant: R01 HL125815,R01 HL133016,R01 HL142674,(D.M.G.),R01 DK097075,R01 HL114457,R01 DK109574,R01 HL119837,HL133900 (H.K.E.);,R01 HL109233,HL125850,HL152677,(E.L.H.)
NIH
Grant: 1K08HL151970
NIDDK NIH HHS
Grant: R01 DK097075
NHLBI NIH HHS
Grant: R01 HL153604
NCATS NIH HHS
Grant: UL1 TR001863
NHLBI NIH HHS
Grant: P01 HL114457
NHLBI NIH HHS
Grant: R01 HL142674
NHLBI NIH HHS
Grant: R03 HL154275
NHLBI NIH HHS
Grant: T32 HL007778
NHLBI NIH HHS
Grant: K08 HL133603
NIDDK NIH HHS
Grant: R01 DK109574
NHLBI NIH HHS
Grant: R01 HL109233
NIDDK NIH HHS
Grant: R01 DK122796
NHLBI NIH HHS
Grant: R01 HL125850
NHLBI NIH HHS
Grant: K01 HL125474
NHLBI NIH HHS
Grant: K08 HL151970
NHLBI NIH HHS
Grant: R01 HL125815
NHLBI NIH HHS
Grant: R01 HL133016
NHLBI NIH HHS
Grant: R01 HL152677
NHLBI NIH HHS
Grant: R01 HL119837
NHLBI NIH HHS
Grant: R01 HL133900
National Institutes of Health
Grant: 5R01HL125815-03
Pathological arterial muscularization and the role of integrins
National Institutes of Health
Grant: 4R01DK097075-04
Proton Pump Inhibitors for Perioperative Acute Kidney Injury
National Institutes of Health
Grant: 5R01HL109233-04
Novel Immunologic Effects of Semaphorin 7a in IPF
National Institutes of Health
Grant: 5K08HL151970-04
Mitochondrial DNA and TLR9 in Pulmonary Fibrosis
National Institutes of Health
Grant: 5R01HL133016-02
Smooth muscle progenitors in vascular remodeling
FWCI
8.73
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 8 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 7 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 8 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 7 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 6 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 6 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 5 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 5 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 4 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 4 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 3 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 3 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 2 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 2 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 1 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 1 of Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Additional file 9 of ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling
Additional file 9 of ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling
Additional file 8 of ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling
Additional file 8 of ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling